Listed

Protalix BioTherapeutics, Inc.

PLXNYSECIK 1006281HealthcareFiscal year ends Dec 31

Reports and events: 399 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Protalix BioTherapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2021-04-3006:44 ET10-K/AAnnual report, amendedPeriod 2020-12-310001558370-21-005321
2021-04-2806:04 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001558370-21-004976
2021-03-3007:38 ET10-KAnnual reportPeriod 2020-12-310001558370-21-003681
2021-03-3007:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-21-003678
2021-02-2307:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001558370-21-001407
2021-02-1606:21 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-022556
2020-12-3007:10 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-20-014567
2020-10-2907:26 ET10-QQuarterly reportPeriod 2020-09-300001558370-20-011974
2020-10-2907:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-20-011970
2020-10-2317:01 ET8-K/A5.07 Shareholder vote results0001558370-20-011697
2020-10-0117:21 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-20-111165
2020-09-0807:53 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-102834
2020-08-1106:54 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-092996
2020-08-1007:04 ET10-QQuarterly reportPeriod 2020-06-300001104659-20-092375
2020-08-1006:56 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-20-092367
2020-06-0817:04 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-20-070904
2020-06-0117:20 ET10-Q/AQuarterly report, amendedPeriod 2020-03-310001104659-20-068485
2020-06-0107:08 ET10-QQuarterly reportPeriod 2020-03-310001104659-20-067982
2020-06-0106:54 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-20-067973
2020-05-2806:57 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-066624
2020-05-1106:58 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-059085
2020-05-1106:06 ET8-K8.01 Other events0001104659-20-059038
2020-04-1516:30 ETDEF 14AProxy statementPeriod 2020-06-070001104659-20-046926
2020-03-1816:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-035325
2020-03-1216:45 ET10-KAnnual reportPeriod 2019-12-310001104659-20-032540
2020-03-1208:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-20-032178
2020-03-1208:04 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-032169
2020-02-1016:16 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-20-013512
2020-02-0606:57 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-011603
2019-12-2006:11 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001104659-19-074602
2019-12-1907:03 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-19-074052
2019-12-0916:12 ET8-K5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-19-070966
2019-11-1806:57 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-19-064875
2019-11-0706:59 ET10-QQuarterly reportPeriod 2019-09-300001104659-19-060804
2019-11-0706:56 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-19-060801
2019-10-1708:43 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-19-054507
2019-10-1516:30 ETDEF 14AProxy statementPeriod 2019-12-090001104659-19-054172
2019-09-2407:21 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-19-045689
2019-08-3016:15 ET8-K3.01 Delisting notice; 9.01 Financial statements and exhibits0001144204-19-043024
2019-08-1316:13 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001144204-19-039539
2019-08-0816:06 ET10-QQuarterly reportPeriod 2019-06-300001144204-19-038552
2019-08-0806:19 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-19-038367
2019-07-2907:09 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001144204-19-036350
2019-07-2216:05 ET8-K5.02 Departure or appointment of officers or directors0001144204-19-035361
2019-06-1707:08 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-19-031092
2019-06-0607:09 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-19-029957
2019-05-3107:00 ET8-K5.07 Shareholder vote results0001144204-19-029036
2019-05-2107:35 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001144204-19-027423
2019-05-0616:06 ET10-QQuarterly reportPeriod 2019-03-310001144204-19-023895
2019-05-0607:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-19-023738

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:48 ET. Listed shows no prices and gives no investment advice.